| Migraine |
1 |
1 |
| Pain |
0 |
0.61 |
| Headache |
0 |
0.33 |
| Neuron |
0 |
0.31 |
| Brain |
0 |
0.3 |
| Blood Vessel |
0 |
0.27 |
| Pain Management |
0 |
0.26 |
| Blood |
0 |
0.23 |
| Nerve |
0 |
0.23 |
| Scalp |
0 |
0.23 |
| Skull |
0 |
0.23 |
| Allergy |
0 |
0.15 |
| Bone |
0 |
0.15 |
| Central Nervous System |
0 |
0.15 |
| Disability |
0 |
0.15 |
| Receptors |
0 |
0.15 |
| Tryptamine |
0 |
0.15 |
| Psychosomatic Disorder |
0 |
0.13 |
| Adverse Effects |
0 |
0.08 |
| Analgesia |
0 |
0.08 |
| Animal Research |
0 |
0.08 |
| Arizona |
0 |
0.08 |
| Artery |
0 |
0.08 |
| Cardiovascular disease |
0 |
0.08 |
| Cranium |
0 |
0.08 |
| Dorsum |
0 |
0.08 |
| Europe |
0 |
0.08 |
| Face |
0 |
0.08 |
| Grant |
0 |
0.08 |
| Herbal Medicine |
0 |
0.08 |
| Immunology |
0 |
0.08 |
| Impairment |
0 |
0.08 |
| Injury |
0 |
0.08 |
| Magnetic Resonance Imaging |
0 |
0.08 |
| Pedal |
0 |
0.08 |
| Stigma |
0 |
0.08 |
| Stress |
0 |
0.08 |
| Travel Medicine |
0 |
0.08 |
| Urticaria |
0 |
0.08 |
| Vein |
0 |
0.08 |
| Asthma |
0 |
0.06 |
| Cardiovascular Risk Management |
0 |
0.03 |
| Complementary and Alternative Medicine |
0 |
0.03 |
| Healthcare and Medical Technology |
0 |
0.03 |
| Patient Safety |
0 |
0.03 |
| Urticaria and Angioedema |
0 |
0.03 |
| Wound Management |
0 |
0.03 |